Key result
Diabetes in Takotsubo syndrome patients was associated with higher longer-term mortality and independently predicted adverse outcomes.
Why the study?
Does concomitant diabetes impact all-cause mortality in patients with Takotsubo syndrome?
Cohort (n=826)
Yes
Does concomitant diabetes impact all-cause mortality in patients with Takotsubo syndrome?
In patients with Takotsubo syndrome, concomitant diabetes is present in about one-fifth of cases and serves as an independent predictor of increased long-term mortality, challenging previous suggestions of a protective effect.
Answers are grounded in this paper and cite their sources.
Diabetes identifies higher-risk Takotsubo patients for monitoring; leaves open whether interventions modify outcomes.
OBJECTIVE In view of low prevalence rates, diabetes is discussed as a protective factor for the occurrence of Takotsubo syndrome (TTS). Furthermore, it was associated with improved outcome in a small single-center analysis. Therefore, this study assessed the prevalence and prognostic relevance of concomitant diabetes in TTS. RESEARCH DESIGN AND METHODS A total of 826 patients with TTS were enrolled in an international, multicenter, registry-based study (eight centers in Italy and Germany). All-cause mortality was compared between patients with diabetes and patients without diabetes, and the independent predictive value of diabetes was evaluated in multivariate regression analysis. RESULTS The prevalence of diabetes was 21.1% (n = 174). TTS patients with diabetes were older (P < 0.001), were more frequently male (P = 0.003), had a higher prevalence of hypertension (P < 0.001), physical triggers (P = 0.041), and typical apical ballooning (P = 0.010), had a lower left ventricular ejection fraction (P = 0.008), had a higher rate of pulmonary edema (P = 0.032), and had a longer hospital stay (P = 0.009). However, 28-day all-cause mortality did not differ between patients with diabetes and patients without diabetes (6.4% vs. 5.7%; hazard ratio [HR] 1.11 [95% CI 0.55–2.25]; P = 0.772). Longer-term follow-up after a median of 2.5 years revealed a significantly higher mortality among TTS patients with diabetes (31.4% vs. 16.5%; P < 0.001), and multivariate regression analysis identified diabetes as an independent predictor of adverse outcome (HR 1.66 [95% CI 1.16–2.39]; P = 0.006). CONCLUSIONS Diabetes is not uncommon in patients with TTS, is associated with increased longer-term mortality rates, and is an independent predictor of adverse outcome irrespective of additional risk factors.
No takes yet. Share an insight, caveat, or question.
Stiermaier et al. (2018) conducted a cohort in Takotsubo syndrome (n=826). Diabetes vs. No diabetes was evaluated on Longer-term adverse outcome (all-cause mortality) (HR 1.66, 95% CI 1.16-2.39, p=0.006). Diabetes in Takotsubo syndrome patients was associated with higher longer-term mortality and independently predicted adverse outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: